Form 4: CVS Health Director Douglas H. Shulman Acquires 2,200 Shares of Common Stock

CVS Health director Douglas H. Shulman acquired 2,200 shares of common stock as part of a semi-annual retainer payment.

Summary

• Douglas H. Shulman, a director at CVS Health, acquired 2,200 shares of common stock on November 21, 2024.
• The shares were acquired at a price of $57.1 per share.
• This transaction was part of a semi-annual retainer payment under the company's 2017 Incentive Compensation Plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a routine transaction related to director compensation, which can be seen as a sign of alignment between management and shareholders.

Positives

• The acquisition of shares by a director may indicate confidence in the company's future performance.

Industry Context

This is a routine filing related to director compensation and is common in publicly traded companies.

Comparison to Industry Standards

• Director compensation in the form of stock grants is a common practice among publicly traded companies, including CVS Health's competitors such as Walgreens Boots Alliance and UnitedHealth Group.
• The amount of stock granted is consistent with typical director compensation packages.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with company performance.

Key Dates

Keywords

CVS Health, stock acquisition, director, Douglas H. Shulman, insider trading, Form 4, retainer payment, incentive compensation plan